GlassScriptPhysician profile
Michael F Ditillo
NPI 1063672194
$403.17
in general payments reported to CMS, 2019-2025
9 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.94 · 2020: $29.58 · 2022: $49.65 · 2023: $21.23 · 2024: $119 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $142.57 | 2020-2024 | |
| Avita Medical Americas, LLC | $84.84 | 2020-2025 | Permeaderm, Recell, Cohealyx |
| Vapotherm INC | $57.44 | 2019 | |
| Stryker Corporation | $28.94 | 2025 | Spy-Phi System, 1788 |
| Teleflex LLC | $28.71 | 2022 | |
| La Jolla Pharmaceutical Company | $21.23 | 2023 | Xerava |
| Smith+Nephew, INC. | $20.94 | 2022 | |
| Cardinal Health 200 LLC | $18.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ditillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.